Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amygdala | 11 | 2015 | 159 | 2.930 |
Why?
|
| Fear | 6 | 2023 | 239 | 2.120 |
Why?
|
| Neurons | 7 | 2017 | 881 | 1.900 |
Why?
|
| Maze Learning | 10 | 2016 | 138 | 1.510 |
Why?
|
| Anti-Anxiety Agents | 5 | 2015 | 107 | 1.360 |
Why?
|
| Anxiety | 6 | 2018 | 422 | 1.260 |
Why?
|
| Extinction, Psychological | 3 | 2023 | 240 | 1.200 |
Why?
|
| Rats, Long-Evans | 16 | 2018 | 203 | 1.180 |
Why?
|
| Neuropeptide Y | 4 | 2015 | 11 | 1.140 |
Why?
|
| Septal Nuclei | 2 | 2016 | 31 | 1.100 |
Why?
|
| Ethanol | 7 | 2015 | 892 | 1.080 |
Why?
|
| Rats | 27 | 2023 | 5300 | 0.980 |
Why?
|
| Vocalization, Animal | 1 | 2023 | 4 | 0.910 |
Why?
|
| Stress, Psychological | 4 | 2018 | 824 | 0.860 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2018 | 79 | 0.790 |
Why?
|
| Behavior, Animal | 8 | 2012 | 470 | 0.730 |
Why?
|
| Parvalbumins | 1 | 2017 | 29 | 0.620 |
Why?
|
| Animals | 30 | 2023 | 20877 | 0.620 |
Why?
|
| Diazepam | 3 | 2006 | 23 | 0.610 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2019 | 1506 | 0.600 |
Why?
|
| Acetylcholine | 2 | 2016 | 64 | 0.600 |
Why?
|
| Hypothalamus, Middle | 1 | 2016 | 4 | 0.590 |
Why?
|
| Central Amygdaloid Nucleus | 2 | 2018 | 16 | 0.590 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2017 | 28 | 0.590 |
Why?
|
| Prosencephalon | 1 | 2016 | 38 | 0.580 |
Why?
|
| Individuality | 2 | 2016 | 44 | 0.580 |
Why?
|
| Orexins | 1 | 2016 | 52 | 0.580 |
Why?
|
| Functional Laterality | 1 | 2017 | 240 | 0.570 |
Why?
|
| Receptors, Opioid, mu | 2 | 2008 | 70 | 0.520 |
Why?
|
| Learning | 1 | 2016 | 186 | 0.500 |
Why?
|
| Receptors, Opioid, delta | 2 | 2006 | 37 | 0.500 |
Why?
|
| Male | 28 | 2023 | 37281 | 0.440 |
Why?
|
| Somatostatin | 1 | 2012 | 36 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2016 | 114 | 0.420 |
Why?
|
| Alcohol Drinking | 2 | 2012 | 805 | 0.420 |
Why?
|
| Exploratory Behavior | 3 | 2012 | 79 | 0.410 |
Why?
|
| Heart Failure | 1 | 2019 | 1179 | 0.370 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 1174 | 0.360 |
Why?
|
| Analysis of Variance | 6 | 2017 | 1039 | 0.360 |
Why?
|
| Enkephalins | 3 | 2006 | 89 | 0.350 |
Why?
|
| Hippocampus | 5 | 2018 | 471 | 0.340 |
Why?
|
| Narcotic Antagonists | 3 | 2008 | 184 | 0.340 |
Why?
|
| Naltrexone | 3 | 2006 | 195 | 0.330 |
Why?
|
| Opioid Peptides | 2 | 2008 | 17 | 0.310 |
Why?
|
| Acetylcholinesterase | 2 | 2023 | 19 | 0.300 |
Why?
|
| Sex Characteristics | 3 | 2006 | 295 | 0.300 |
Why?
|
| Exercise Test | 2 | 2004 | 242 | 0.280 |
Why?
|
| Benzodiazepines | 1 | 2006 | 130 | 0.280 |
Why?
|
| Receptor, Insulin | 3 | 2015 | 71 | 0.260 |
Why?
|
| Anxiety Disorders | 1 | 2008 | 426 | 0.250 |
Why?
|
| Corticosterone | 3 | 2015 | 51 | 0.250 |
Why?
|
| Predatory Behavior | 2 | 2016 | 10 | 0.250 |
Why?
|
| Motor Activity | 2 | 2006 | 621 | 0.250 |
Why?
|
| Odorants | 2 | 2016 | 52 | 0.240 |
Why?
|
| Conditioning, Classical | 2 | 2016 | 57 | 0.240 |
Why?
|
| Gene Expression | 1 | 2006 | 770 | 0.230 |
Why?
|
| Cholinergic Agents | 1 | 2023 | 12 | 0.230 |
Why?
|
| Rats, Transgenic | 1 | 2023 | 24 | 0.230 |
Why?
|
| Ultrasonics | 1 | 2023 | 17 | 0.230 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 209 | 0.220 |
Why?
|
| Herpesvirus 1, Human | 2 | 2016 | 30 | 0.220 |
Why?
|
| Reproduction | 1 | 2002 | 48 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2002 | 215 | 0.190 |
Why?
|
| Disease Models, Animal | 5 | 2016 | 2550 | 0.190 |
Why?
|
| Central Nervous System Depressants | 3 | 2006 | 182 | 0.180 |
Why?
|
| Neuronal Plasticity | 2 | 2015 | 274 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2018 | 2083 | 0.180 |
Why?
|
| Hypothalamus | 3 | 2014 | 78 | 0.180 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1293 | 0.180 |
Why?
|
| Freezing Reaction, Cataleptic | 2 | 2016 | 10 | 0.170 |
Why?
|
| Electroshock | 2 | 2016 | 36 | 0.170 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2018 | 52 | 0.170 |
Why?
|
| Dominance-Subordination | 1 | 2018 | 11 | 0.160 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 307 | 0.150 |
Why?
|
| Genetic Vectors | 3 | 2011 | 311 | 0.150 |
Why?
|
| Cell Count | 1 | 2017 | 248 | 0.150 |
Why?
|
| Epilepsy, Reflex | 1 | 2016 | 1 | 0.150 |
Why?
|
| Inferior Colliculi | 1 | 2016 | 3 | 0.150 |
Why?
|
| Glutamate Decarboxylase | 1 | 2016 | 18 | 0.150 |
Why?
|
| Animals, Outbred Strains | 1 | 2016 | 4 | 0.150 |
Why?
|
| Mental Recall | 1 | 2016 | 72 | 0.140 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2016 | 3 | 0.140 |
Why?
|
| Acoustic Stimulation | 1 | 2016 | 206 | 0.140 |
Why?
|
| Female | 9 | 2023 | 38015 | 0.130 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2016 | 257 | 0.130 |
Why?
|
| Spatial Learning | 1 | 2015 | 12 | 0.130 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 306 | 0.130 |
Why?
|
| Receptors, GABA-A | 2 | 2006 | 89 | 0.130 |
Why?
|
| Obesity | 2 | 2014 | 1074 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 244 | 0.130 |
Why?
|
| Protein Precursors | 2 | 2006 | 105 | 0.130 |
Why?
|
| Seizures | 1 | 2016 | 279 | 0.120 |
Why?
|
| Food Deprivation | 1 | 2014 | 22 | 0.120 |
Why?
|
| Anhedonia | 1 | 2014 | 15 | 0.120 |
Why?
|
| Leptin | 2 | 2011 | 80 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2015 | 241 | 0.120 |
Why?
|
| Brain | 2 | 2019 | 2175 | 0.110 |
Why?
|
| Ferrets | 1 | 2012 | 3 | 0.110 |
Why?
|
| Cues | 1 | 2016 | 654 | 0.110 |
Why?
|
| Limbic System | 1 | 2012 | 106 | 0.100 |
Why?
|
| Time Factors | 3 | 2005 | 4655 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 102 | 0.100 |
Why?
|
| Veterans | 1 | 2019 | 904 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 567 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 296 | 0.100 |
Why?
|
| Food Preferences | 2 | 2011 | 46 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 329 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2011 | 447 | 0.090 |
Why?
|
| Depression | 2 | 2018 | 942 | 0.080 |
Why?
|
| Humans | 5 | 2019 | 68525 | 0.080 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2008 | 27 | 0.080 |
Why?
|
| Microdialysis | 2 | 2012 | 147 | 0.080 |
Why?
|
| Smell | 1 | 2008 | 131 | 0.070 |
Why?
|
| United States | 1 | 2019 | 7335 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 710 | 0.070 |
Why?
|
| RNA, Antisense | 1 | 2006 | 25 | 0.070 |
Why?
|
| Enkephalin, Methionine | 1 | 2006 | 20 | 0.070 |
Why?
|
| Microinjections | 1 | 2006 | 130 | 0.070 |
Why?
|
| DNA, Antisense | 1 | 2005 | 9 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2008 | 323 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2006 | 289 | 0.070 |
Why?
|
| Testosterone | 1 | 2005 | 96 | 0.070 |
Why?
|
| Aggression | 1 | 2005 | 98 | 0.070 |
Why?
|
| Arginine | 1 | 2005 | 102 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 1047 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2006 | 154 | 0.060 |
Why?
|
| Self Administration | 1 | 2006 | 419 | 0.060 |
Why?
|
| Body Weight | 3 | 2014 | 554 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 782 | 0.060 |
Why?
|
| Olfactory Pathways | 1 | 2003 | 9 | 0.060 |
Why?
|
| Olfactory Bulb | 1 | 2003 | 14 | 0.060 |
Why?
|
| Estrous Cycle | 1 | 2003 | 23 | 0.060 |
Why?
|
| Herpesviridae | 1 | 2003 | 11 | 0.060 |
Why?
|
| Psychomotor Agitation | 1 | 2003 | 63 | 0.060 |
Why?
|
| Pyramidal Cells | 1 | 2003 | 79 | 0.060 |
Why?
|
| Aged | 1 | 2019 | 14842 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2003 | 173 | 0.060 |
Why?
|
| Radioimmunoassay | 1 | 2002 | 164 | 0.050 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 124 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2002 | 34 | 0.050 |
Why?
|
| Dendrites | 1 | 2002 | 44 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 498 | 0.050 |
Why?
|
| Restraint, Physical | 1 | 2002 | 59 | 0.050 |
Why?
|
| Rats, Wistar | 1 | 2002 | 371 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1663 | 0.050 |
Why?
|
| Middle Aged | 1 | 2019 | 21119 | 0.050 |
Why?
|
| Adult | 1 | 2019 | 21375 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2002 | 236 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1745 | 0.050 |
Why?
|
| Eating | 2 | 2014 | 119 | 0.040 |
Why?
|
| Ovariectomy | 1 | 2018 | 49 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2018 | 46 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 88 | 0.040 |
Why?
|
| Heart Rate | 1 | 2018 | 568 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 2015 | 99 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2015 | 266 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 1199 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2012 | 104 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2011 | 16 | 0.030 |
Why?
|
| Inflammation | 1 | 2018 | 1030 | 0.030 |
Why?
|
| Swimming | 1 | 2011 | 38 | 0.020 |
Why?
|
| Triglycerides | 1 | 2011 | 184 | 0.020 |
Why?
|
| Adiposity | 1 | 2011 | 88 | 0.020 |
Why?
|
| Memory | 1 | 2012 | 214 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2012 | 208 | 0.020 |
Why?
|
| Pregnancy | 2 | 2006 | 2331 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 866 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2012 | 332 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2006 | 25 | 0.020 |
Why?
|
| Fetal Alcohol Spectrum Disorders | 1 | 2006 | 27 | 0.020 |
Why?
|
| Housing | 1 | 2005 | 38 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2006 | 173 | 0.020 |
Why?
|
| Birth Weight | 1 | 2006 | 186 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2006 | 396 | 0.020 |
Why?
|
| Gestational Age | 1 | 2006 | 389 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2005 | 328 | 0.020 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2003 | 4 | 0.020 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2003 | 9 | 0.020 |
Why?
|
| Indole Alkaloids | 1 | 2003 | 18 | 0.010 |
Why?
|
| Receptor, trkB | 1 | 2003 | 27 | 0.010 |
Why?
|
| Receptors, Nicotinic | 1 | 2003 | 41 | 0.010 |
Why?
|
| Carbazoles | 1 | 2003 | 46 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 2003 | 45 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 251 | 0.010 |
Why?
|
| Models, Neurological | 1 | 2003 | 136 | 0.010 |
Why?
|
| Action Potentials | 1 | 2003 | 223 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 472 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2003 | 682 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 659 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2003 | 2673 | 0.010 |
Why?
|